硬化症-话题@MedSci

#硬化症#

413篇内容 | 2617人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1983189, encodeId=12d01983189f6, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=NNN：年轻成人超重/肥胖与多发性硬化症病因学中EBV感染方面的关系, objectType=article, longId=217549, objectId=81b721e549e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81b721e549e8, replyNumber=0, likeNumber=72, createdTime=2021-12-15, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81b721e549e8, moduleTitle=NNN：年轻成人超重/肥胖与多发性硬化症病因学中EBV感染方面的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81b721e549e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983185, encodeId=098b1983185ec, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：Occrelizumab在不同类型的多发性硬化症患者中的安全性, objectType=article, longId=216853, objectId=451721685336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=451721685336, replyNumber=0, likeNumber=72, createdTime=2022-01-30, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=451721685336, moduleTitle=Neurology：Occrelizumab在不同类型的多发性硬化症患者中的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=451721685336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983247, encodeId=f62d198324e82, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Dermatol Ther：体外光疗治疗系统性硬化症的疗效与安全性, objectType=article, longId=733075, objectId=612de3307549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=612de3307549, replyNumber=0, likeNumber=70, createdTime=2022-09-11, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=612de3307549, moduleTitle=Dermatol Ther：体外光疗治疗系统性硬化症的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=612de3307549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983193, encodeId=7b411983193a7, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Mult Scler：复发缓解型多发性硬化症患者应用单一SARS-COV-2疫苗后血清转换率降低, objectType=article, longId=218282, objectId=953321828287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953321828287, replyNumber=0, likeNumber=90, createdTime=2021-11-20, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953321828287, moduleTitle=Mult Scler：复发缓解型多发性硬化症患者应用单一SARS-COV-2疫苗后血清转换率降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=953321828287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983224, encodeId=1587198322490, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=ARD:外周血基因表达谱显示对系统性硬化症相关间质性肺病中霉酚酸酯反应的预测意义, objectType=article, longId=300841, objectId=0a0e3008415a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a0e3008415a, replyNumber=0, likeNumber=0, createdTime=2022-11-15, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a0e3008415a, moduleTitle=ARD:外周血基因表达谱显示对系统性硬化症相关间质性肺病中霉酚酸酯反应的预测意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a0e3008415a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983200, encodeId=42a01983200a3, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫, objectType=article, longId=219212, objectId=25c4219212b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25c4219212b0, replyNumber=0, likeNumber=69, createdTime=2022-06-02, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25c4219212b0, moduleTitle=JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25c4219212b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983242, encodeId=f3761983242aa, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=A&R：尼达尼布可以减缓系统性硬化症相关间质性肺病（ILD）患者的肺功能下降速度, objectType=article, longId=730001, objectId=e01be30001dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01be30001dd, replyNumber=0, likeNumber=76, createdTime=2022-12-04, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01be30001dd, moduleTitle=A&R：尼达尼布可以减缓系统性硬化症相关间质性肺病（ILD）患者的肺功能下降速度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01be30001dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983216, encodeId=51cb1983216cc, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neural Regen Res：复发-缓解型多发性硬化症的海马结构、功能连接与认知功能、残疾程度有关, objectType=article, longId=293877, objectId=ffe42938e753, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffe42938e753, replyNumber=0, likeNumber=87, createdTime=2022-05-22, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffe42938e753, moduleTitle=Neural Regen Res：复发-缓解型多发性硬化症的海马结构、功能连接与认知功能、残疾程度有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffe42938e753)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983203, encodeId=461d198320315, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet Neurol：无功无过——间充质干细胞与安慰剂治疗多发性硬化症(MESEMS)的安全性、耐受性和活性的研究, objectType=article, longId=219450, objectId=ebb921945031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebb921945031, replyNumber=0, likeNumber=70, createdTime=2022-07-13, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebb921945031, moduleTitle=Lancet Neurol：无功无过——间充质干细胞与安慰剂治疗多发性硬化症(MESEMS)的安全性、耐受性和活性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebb921945031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983230, encodeId=2e111983230c5, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet Rheumatolgoy：异体骨髓来源的多能间充质基质细胞治疗系统性硬化症的安全性和初步疗效, objectType=article, longId=724013, objectId=3715e2401321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3715e2401321, replyNumber=0, likeNumber=111, createdTime=2022-12-22, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3715e2401321, moduleTitle=Lancet Rheumatolgoy：异体骨髓来源的多能间充质基质细胞治疗系统性硬化症的安全性和初步疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3715e2401321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983227, encodeId=d87f198322e6c, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Brain：这些因素与早期多发性硬化症的病情进展与复发有关！, objectType=article, longId=301938, objectId=f36d30193801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f36d30193801, replyNumber=0, likeNumber=85, createdTime=2023-02-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f36d30193801, moduleTitle=Brain：这些因素与早期多发性硬化症的病情进展与复发有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f36d30193801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983233, encodeId=86f819832339e, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=European Radiology：钆基造影剂对多发性硬化症患者脑萎缩自动测量的影响, objectType=article, longId=724041, objectId=7671e24041ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7671e24041ca, replyNumber=0, likeNumber=80, createdTime=2022-05-24, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7671e24041ca, moduleTitle=European Radiology：钆基造影剂对多发性硬化症患者脑萎缩自动测量的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7671e24041ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983194, encodeId=410c19831948c, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果, objectType=article, longId=218566, objectId=6499218566f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6499218566f3, replyNumber=0, likeNumber=90, createdTime=2021-11-16, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6499218566f3, moduleTitle=BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6499218566f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983241, encodeId=f7fb198324132, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=A&R：白细胞介素1β激活的微血管内皮细胞在系统性硬化症中皮肤纤维化的机制, objectType=article, longId=729717, objectId=7b4ee2971742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4ee2971742, replyNumber=0, likeNumber=98, createdTime=2023-05-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4ee2971742, moduleTitle=A&R：白细胞介素1β激活的微血管内皮细胞在系统性硬化症中皮肤纤维化的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4ee2971742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983223, encodeId=b4f5198322310, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle= JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响, objectType=article, longId=300584, objectId=fbce30058427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbce30058427, replyNumber=0, likeNumber=71, createdTime=2022-03-24, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbce30058427, moduleTitle= JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbce30058427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983207, encodeId=603b198320ef7, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=苏格兰药物联盟 (SMC)批准Ponvory (ponsimod)治疗复发性多发性硬化症（内容较少，麻烦补充，谢谢）, objectType=article, longId=220349, objectId=a6392203493e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6392203493e, replyNumber=0, likeNumber=46, createdTime=2022-09-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6392203493e, moduleTitle=苏格兰药物联盟 (SMC)批准Ponvory (ponsimod)治疗复发性多发性硬化症（内容较少，麻烦补充，谢谢）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6392203493e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983198, encodeId=8c9819831989f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JNNP:肌萎缩侧索硬化症胸椎型变异的分型, objectType=article, longId=219034, objectId=6c872190347e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c872190347e, replyNumber=0, likeNumber=120, createdTime=2022-01-28, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c872190347e, moduleTitle=JNNP:肌萎缩侧索硬化症胸椎型变异的分型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c872190347e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983212, encodeId=d28e1983212cd, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet Rheumatology: 雷诺现象患者向系统性硬化症的进展, objectType=article, longId=265001, objectId=fb8c265001b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb8c265001b6, replyNumber=0, likeNumber=67, createdTime=2022-05-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb8c265001b6, moduleTitle=Lancet Rheumatology: 雷诺现象患者向系统性硬化症的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb8c265001b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983208, encodeId=a62819832089d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=干细胞新药重大进展：多发性硬化症在研T-MSC干细胞新药在美完成首例患者用药, objectType=article, longId=220620, objectId=9019220620b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9019220620b8, replyNumber=0, likeNumber=120, createdTime=2022-07-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9019220620b8, moduleTitle=干细胞新药重大进展：多发性硬化症在研T-MSC干细胞新药在美完成首例患者用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9019220620b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983186, encodeId=eb3d198318656, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JNER:多发性硬化症、帕金森病患者和健康对照者的实验室步态特征与日常生活步态特征, objectType=article, longId=216961, objectId=e940216961e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e940216961e2, replyNumber=0, likeNumber=79, createdTime=2022-06-02, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e940216961e2, moduleTitle=JNER:多发性硬化症、帕金森病患者和健康对照者的实验室步态特征与日常生活步态特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e940216961e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

NNN：年轻成人超重/肥胖与多发性硬化症病因学中EBV感染方面的关系

2021-12-15

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：Occrelizumab在不同类型的多发性硬化症患者中的安全性

2022-01-30

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Dermatol Ther：体外光疗治疗系统性硬化症的疗效与安全性

2022-09-11

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Mult Scler：复发缓解型多发性硬化症患者应用单一SARS-COV-2疫苗后血清转换率降低

2021-11-20

30397604 (审核中...)

前往app查看评论内容

#硬化症#

ARD:外周血基因表达谱显示对系统性硬化症相关间质性肺病中霉酚酸酯反应的预测意义

2022-11-15

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JNNP：多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫

2022-06-02

30397604 (审核中...)

前往app查看评论内容

#硬化症#

A&R：尼达尼布可以减缓系统性硬化症相关间质性肺病（ILD）患者的肺功能下降速度

2022-12-04

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neural Regen Res：复发-缓解型多发性硬化症的海马结构、功能连接与认知功能、残疾程度有关

2022-05-22

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet Neurol：无功无过——间充质干细胞与安慰剂治疗多发性硬化症(MESEMS)的安全性、耐受性和活性的研究

2022-07-13

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet Rheumatolgoy：异体骨髓来源的多能间充质基质细胞治疗系统性硬化症的安全性和初步疗效

2022-12-22

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Brain：这些因素与早期多发性硬化症的病情进展与复发有关！

2023-02-25

30397604 (审核中...)

前往app查看评论内容

#硬化症#

European Radiology：钆基造影剂对多发性硬化症患者脑萎缩自动测量的影响

2022-05-24

30397604 (审核中...)

前往app查看评论内容

#硬化症#

BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果

2021-11-16

30397604 (审核中...)

前往app查看评论内容

#硬化症#

A&R：白细胞介素1β激活的微血管内皮细胞在系统性硬化症中皮肤纤维化的机制

2023-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响

2022-03-24

30397604 (审核中...)

前往app查看评论内容

#硬化症#

苏格兰药物联盟 (SMC)批准Ponvory (ponsimod)治疗复发性多发性硬化症（内容较少，麻烦补充，谢谢）

2022-09-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JNNP:肌萎缩侧索硬化症胸椎型变异的分型

2022-01-28

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet Rheumatology: 雷诺现象患者向系统性硬化症的进展

2022-05-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

干细胞新药重大进展：多发性硬化症在研T-MSC干细胞新药在美完成首例患者用药

2022-07-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JNER:多发性硬化症、帕金森病患者和健康对照者的实验室步态特征与日常生活步态特征

2022-06-02

科室
- - 订阅+
  - 更多科室
工具
服务